Nellore Capital Management LLC Has $85.99 Million Position in Veeva Systems Inc. $VEEV

Nellore Capital Management LLC increased its stake in shares of Veeva Systems Inc. (NYSE:VEEV) by 8.3% during the 2nd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 484,515 shares of the technology company’s stock after buying an additional 37,214 shares during the period. Veeva Systems accounts for approximately 9.5% of Nellore Capital Management LLC’s holdings, making the stock its 5th biggest holding. Nellore Capital Management LLC owned about 0.30% of Veeva Systems worth $85,987,000 as of its most recent SEC filing.

A number of other hedge funds have also recently added to or reduced their stakes in VEEV. Nykredit A S acquired a new stake in shares of Veeva Systems in the second quarter valued at approximately $12,297,000. Investors Research Corp bought a new stake in shares of Veeva Systems during the second quarter worth $368,000. Proficio Capital Partners LLC bought a new stake in shares of Veeva Systems during the second quarter worth approximately $258,000. Nwam LLC boosted its stake in Veeva Systems by 16.3% in the second quarter. Nwam LLC now owns 16,385 shares of the technology company’s stock valued at $2,908,000 after acquiring an additional 2,301 shares during the last quarter. Finally, Fundsmith LLP acquired a new stake in Veeva Systems during the 2nd quarter worth $144,955,000. Institutional investors own 88.20% of the company’s stock.

Analyst Upgrades and Downgrades

Several research analysts have recently issued reports on VEEV shares. Royal Bank Of Canada raised their price target on Veeva Systems from $275.00 to $325.00 and gave the stock an “outperform” rating in a research report on Thursday, August 27th. BNP Paribas Exane reiterated an “outperform” rating and issued a $285.00 price target on shares of Veeva Systems in a research report on Thursday, June 4th. Robert W. Baird upped their target price on shares of Veeva Systems from $260.00 to $300.00 and gave the company an “outperform” rating in a research note on Thursday, August 27th. UBS Group lifted their price target on shares of Veeva Systems from $190.00 to $290.00 and gave the stock a “neutral” rating in a research report on Thursday, August 27th. Finally, Weiss Ratings raised Veeva Systems from a “hold (c-)” rating to a “hold (c)” rating in a research note on Wednesday, August 12th. Nineteen analysts have rated the stock with a Buy rating, eight have issued a Hold rating and one has given a Sell rating to the stock. According to MarketBeat, the company presently has an average rating of “Moderate Buy” and an average target price of $284.46.

Veeva Systems Stock Performance

Shares of VEEV opened at $281.25 on Thursday. The firm has a market cap of $45.69 billion, a P/E ratio of 46.26, a PEG ratio of 1.19 and a beta of 0.97. Veeva Systems Inc. has a twelve month low of $148.05 and a twelve month high of $310.50. The firm’s 50 day moving average price is $215.92 and its two-hundred day moving average price is $186.57.

Veeva Systems (NYSE:VEEV) last issued its quarterly earnings results on Wednesday, August 26th. The technology company reported $2.35 EPS for the quarter, beating analysts’ consensus estimates of $2.23 by $0.12. Veeva Systems had a return on equity of 14.25% and a net margin of 29.34%.The company had revenue of $927.96 million for the quarter, compared to analyst estimates of $905.38 million. During the same period in the previous year, the company posted $1.99 earnings per share. The company’s quarterly revenue was up 17.6% compared to the same quarter last year. Veeva Systems has set its FY 2027 guidance at 9.210-9.210 EPS and its Q3 2027 guidance at 2.330-2.340 EPS. On average, sell-side analysts anticipate that Veeva Systems Inc. will post 6.7 earnings per share for the current fiscal year.

Insider Activity

In related news, insider Thomas D. Schwenger sold 10,000 shares of the firm’s stock in a transaction on Thursday, August 27th. The shares were sold at an average price of $281.33, for a total value of $2,813,300.00. Following the completion of the transaction, the insider owned 19,449 shares of the company’s stock, valued at approximately $5,471,587.17. This trade represents a 33.96% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 10.60% of the stock is owned by company insiders.

Trending Headlines about Veeva Systems

Here are the key news stories impacting Veeva Systems this week:

• Positive Sentiment: Strong results and outlook support the rally. Veeva’s latest quarterly revenue rose 17.6% year over year to $927.96 million, exceeding estimates of $905.38 million. Adjusted earnings of $2.35 per share also topped the $2.23 consensus estimate. The company raised or maintained forward guidance, including fiscal 2027 EPS guidance of approximately $9.21 and third-quarter guidance of $2.33 to $2.34. Veeva Rises on Sales and Margin Gains, Guidance Raise
• Positive Sentiment: Falcon Safety expands Veeva’s AI-driven product offering. The company launched Veeva Falcon Safety, an agentic safety-operations product designed to automate adverse-event intake, case processing, and follow-up across all E2B-compliant safety systems and intake channels. The product could help biopharmaceutical customers reduce costs, improve processing speed, and maintain regulatory compliance, potentially creating additional growth opportunities. Veeva Falcon Safety to Work with All E2B-Compliant Safety Systems Across Any Intake Channels
• Positive Sentiment: Analyst sentiment has improved. An analyst upgrade helped lift investor confidence, while recent price-target increases—including RBC’s target of $325—reinforce the view that earnings momentum may justify additional upside. Veeva Systems Trading Up After Analyst Upgrade
• Neutral Sentiment: Veeva will present at the Wells Fargo 21st Annual Healthcare Conference. The event may provide updates on strategy and demand, but the announcement itself does not change financial forecasts. Veeva to Present at Upcoming Investor Conferences
• Negative Sentiment: Insider selling creates a modest sentiment risk. Exiting President Thomas Schwenger sold 10,000 shares for roughly $2.8 million, reducing his direct holdings substantially. Because the transaction was made under a pre-arranged Rule 10b5-1 plan, it may reflect scheduled portfolio management rather than a negative view of Veeva’s prospects. Veeva’s Exiting President Sold $2.8 Million in Stock
• Negative Sentiment: Investor Michael Burry also trimmed his Veeva position after the stock nearly doubled, potentially adding short-term selling pressure and highlighting concerns about the shares’ elevated valuation.

About Veeva Systems

Veeva Systems (NYSE: VEEV) is a cloud software company that develops industry-specific applications and data solutions for the global life sciences sector. Founded in 2007 and headquartered in Pleasanton, California, Veeva focuses on helping pharmaceutical, biotechnology, medical device and consumer health companies manage regulated content, clinical and regulatory processes, quality systems, and commercial operations in a compliant, cloud-native environment. The company completed its initial public offering in 2013 and has since expanded its product suite and international footprint.

Veeva’s product portfolio centers on its Vault platform and related application suites, which provide content and data management, clinical trial and regulatory workflows, quality management, and structured commercial capabilities such as customer relationship management and promotional content management.